April ADP US Private Payrolls Rise Less Than Expected Ahead of BLS Data

-- ADP's monthly measure of private payrolls showed a 109,000 increase in April, below expectations compiled by Bloomberg as of 7:20 am ET for an increase of 120,000.

The April gain followed a downwardly revised 61,000 increase in March.

By sector, goods-producing jobs rose by 15,000, led by a 10,000 increase in construction jobs, while service-providing jobs were up 94,000, with education and health services jobs up 61,000, trade, transportation, and utilities jobs up 25,000, and leisure and hospitality jobs up 4,000.

Pay growth for job-changers held steady at a 6.6% gain year-over-year, while pay growth for job-stayers decelerated slightly to 4.4% year-over-year.

"Small and large employers are hiring, but we're seeing softness in the middle," said Nela Richardson, chief economist at ADP. "Large companies have resources to deploy, and small ones are the most nimble, both important advantages in a complex labor environment."

Wedbush 将 AMD 的目标股价从 400 美元上调至 450 美元，维持“跑赢大盘”评级。

根据FactSet调查的分析师数据，AMD的平均评级为“买入”，平均目标价为410.23美元。（报道北美、亚洲和欧洲主要银行及研究机构的股票、商品和经济研究。研究机构可通过以下链接联系我们：https://www..com/contact-us）Price: $411.80, Change: $+56.54, Percent Change: +15.92%

$AMD

Truist Securities 将 Hinge Health 的目标股价从 63 美元上调至 79 美元，维持“买入”评级。

根据FactSet调查的分析师报告，Hinge Health, Inc. A类股（HNGE）的平均评级为“买入”，平均目标价为68.20美元。（报道北美、亚洲和欧洲主要银行及研究机构的股票、商品和经济研究。研究机构可通过以下链接联系我们：https://www..com/contact-us）Price: $54.69, Change: $+4.94, Percent Change: +9.93%

$HNGE

Truist 将 Integra LifeSciences 的目标股价从 12 美元上调至 14 美元，维持“持有”评级。

根据FactSet调查的分析师数据，Integra LifeSciences (IART) 的平均评级为“持有”，平均目标价为17.17美元。（报道北美、亚洲和欧洲主要银行及研究机构的股票、商品和经济研究。研究机构可通过以下链接联系我们：https://www..com/contact-us）Price: $13.34, Change: $+0.12, Percent Change: +0.91%

$IART

相关文章

Wedbush 将 AMD 的目标股价从 400 美元上调至 450 美元，维持“跑赢大盘”评级。

Truist Securities 将 Hinge Health 的目标股价从 63 美元上调至 79 美元，维持“买入”评级。

Truist 将 Integra LifeSciences 的目标股价从 12 美元上调至 14 美元，维持“持有”评级。